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Objectives   The objective was to examine if night shift work is a short-term risk factor for breast cancer, includ-
ing combined estrogen receptor (ER) and human epidermal growth factor 2 (HER2) breast cancer subtypes.
Methods   The cohort comprised 155 540 public sector female workers in Denmark who were followed from 
2007–2012. Day-to-day work-hour information was available from payroll registers and 1245 incident cases of 
breast cancer were identified in national cancer registries together with receptor subtype information.
Results   A rate ratio (RR) of 0.90 [95% confidence interval (95% CI) 0.80–1.01] was observed for workers 
ever working night shifts during the follow-up period compared with workers only working day shifts after 
adjustment for age, age at first child, parity, family history of breast or ovarian cancer, sex hormones, medica-
tions related to alcoholism, family educational level, mammography screening, and other potential confounders. 
Comparable results were seen for the inception population of employees with first recorded employment after 
2007. Modestly increased RR were suggested for breast cancer subtypes characterized by a positive HER2 status 
irrespective of ER status. 
Conclusions   These findings do not support an overall short-term effect of night shift work on breast cancer 
risk. Future studies should explore further the impact of HER2 status.
Key terms   circadian disruption; epidemiology; shift worker; working time. 
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In 2007, a working group convened by the International 
Agency for Research on Cancer (IARC) classified night 
shift work that involves circadian disruption as probably 
carcinogenic to humans based on sufficient evidence in 
animals, and limited evidence in humans (1). Since then 
several epidemiologic studies and systematic reviews 
have been published, but despite these efforts the epi-
demiological evidence is still limited (2–5).
Reduction of nocturnal pineal melatonin production 
is suggested as a pivotal element of the mechanisms 
linking night shift work and breast cancer (6–13). From 
animal studies it is known that melatonin reduces the 
growth of chemically induced mammary tumors (10, 
14). It has also been shown that melatonin at physiologi-
cal levels suppresses the proliferation of human breast 
cancer xenografts (15–17). Furthermore, melatonin may 
reduce the invasiveness of human breast cancer, and the 
suppression of melatonin during the biological night may 
act as a promoter of oncogenesis (10, 16). This experi-
mental evidence suggests that suppression of melatonin 
from night shift work may exert its response downstream 
the complex casual pathways that lead to breast cancer. 
Hence, recent night shift work may be associated with 
short-term risk of breast cancer in humans. 
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Of the several epidemiologic studies conducted, only 
three studies have examined possible short-term risk of 
recent night shift work (18–20). Davis et al observed an 
increased risk of breast cancer among women who ever 
worked the graveyard shift during the last ten years (19). 
However, Pesch et al (18) did not corroborate this finding. 
The well-established effects of prolonged exposure of 
breast tissue to estrogen vary according to breast cancer 
receptor subtypes and are most consistent for the hor-
mone dependent tumors (21–23). This suggests distinct 
etiologic pathways for breast cancer subtypes and new 
risk factors may be overseen if this is not accounted 
for (24). Night shift work has been associated with 
estrogen receptor positive (ER+) (25–29), ER- (26, 30), 
progesterone receptor positive (PR+) (26–29), human 
epidermal growth factor 2 positive (HER2+) (29, 31) 
and HER2- breast cancer subtypes (29). The strongest 
association was reported for HER2+ in combination 
with ER+ or PR+ receptor status (29). 
Previous studies of the association between night 
shift work and breast cancer have relied on crude and 
self-reported information on working time, and find-
ings may have been influenced by non-differential as 
well as differential misclassification of exposure that 
perhaps only can be circumvented by continuously 
and objectively recorded information of working 
hours (2). 
The present study combines day-to-day informa-
tion on exact working time obtained from a large and 
recently established payroll register with cancer inci-
dence and tumor receptor subtype information. The 
objective was to examine if night shift work is a short-
term risk factor for overall breast cancer and combined 
ER and HER2 receptor breast cancer subtypes. 
Methods
Data sources
This study linked information from seven Danish 
registries on the individual level by use of the civil 
registration number given to all residents in Denmark 
since 1968: (i) The Danish Working Hour Database 
is a newly established database encompassing all 
employees of each of the five administrative regions, 
which operate in healthcare and other public sectors. 
The database covers individual payroll information 
on day, hour, and minute of the beginning and end of 
every work shift and information on occupation. Data 
have been available since 1 January 2007 for four of 
the regions and from 2008 for all regions; (ii) The 
Civil Registration System encompasses all residents 
in Denmark with information on sex, vital status, date 
of birth and links to first degree relatives since 1968 
(32); (iii) The clinical database of the Danish Breast 
Cancer Corporative Group includes pathological and 
clinical information on all new diagnosed breast can-
cers diagnosed since 1977 as well as information on 
ER and HER2 status (33); (iv) The Danish Cancer 
Registry keeps records on all cancers diagnosed clas-
sified according to ICD-7 and ICD-10 codes (the 
International Classification of Diseases), and date of 
diagnosis since 1943 (34); (v) The National Register 
of Medicinal Product Statistics encompasses all pur-
chases of prescription drugs at private pharmacies with 
information on the medication by ATC codes (the Ana-
tomical Therapeutic Chemical Classification System), 
date of purchase, and purchaser (35). Data have been 
available since 1995; (vi) The Family Income Register 
from Statistics Denmark encompasses all individuals 
born or living in Denmark with information on the 
highest educational level in a family living at the same 
address (36). We included information as of 1 January 
2007; (vii) The Clinical Database of Mammography 
Screening records women aged 50–69 years and invited 
to participate in the national mammography screening 
programme (37). The database includes information on 
dates of invitation and examination since the start of 
the program by the end of 2007.
Data were retrieved up to and including 31 Decem-
ber 2012 for all registers, though Danish Cancer Reg-
istry data were only available up to 31 December 2011.
The Danish Data Protection Agency approved the 
study (j.no. 2011-41-6850). In Denmark, register studies 
do not need the approval of the Danish Health Research 
Ethics Committee System.
Study population
The study population was women aged ≥18 years with 
≥1 registration of work in the Danish Working Hour 
Database between 1 January 2007 and 31 Decem-
ber 2011 (N=156 927). We excluded 1357 women 
diagnosed with breast cancer prior to follow-up, one 
woman with missing date of breast cancer diagnosis, 
and 29 women who had <3 consecutive hours of work. 
The final study population included 155 540 women 
free of breast cancer at start of follow-up. 
We had no information on the study participants’ 
working hours prior to 2007. Therefore, to reduce pos-
sible bias and confounding from night shift work prior 
to 2007 we established a sub-population of subjects 
first employed by 1 January 2008 or later (the inception 
population). This included subjects with no recorded 
employment in any of the regions during 2007 (wash-
out period) and was possible for employees in four of 
the five regions. In total 55 381 (35.6%) fulfilled the 
criterion.
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Breast cancer cases and date of diagnosis together with 
information on ER and HER2 status were identified in 
the clinical database of the Danish Breast Cancer Cor-
porative Group for all available years and supplemented 
with breast cancer cases from the Danish Cancer Regis-
try [ICD-10 code C50 (1978–2012) or ICD-7 code 170 
(<1978)]. Cases were classified into four subtypes on 
the basis of their ER and HER2 status: (i) ER-/HER2-, 
(ii) ER+/HER2-, (iii) ER-/HER2+, and (iv) ER+/HER2+ 
tumors. Progesterone receptor status is strongly associ-
ated with ER status and has not been routinely analyzed 
in Denmark since 2007. Information on PR status was 
only available for a small subset of cases and was not 
included for the analyses. 
ER status was defined using a cut-off at 10% posi-
tive estrogen cells. HER2 status was established using 
immunohistological markers from 0–3+, where 2+ is 
regarded as "equivocal", and 3+ as positive. In cases 
which were equivocal (2+), the immunohistological test 
was supplied with fluorescence or chromogenic in situ 
hybridization (FISH and CISH test, respectively), and 
the tumor was classified as positive (HER2+) if onco-
genic amplification was found (38). 
Definition of shifts
A night shift was defined according to a 2009 IARC 
working group as ≥3 hours of work between midnight 
and 05:00 hours (39). We defined a day shift as ≥3 hours 
of work between 06:00–20:00 hours and all other shifts 
of ≥3 hours as a non-day, non-night shift. In the analy-
ses, we considered six different exposure time windows: 
Since entry, and the past 1, 1–2, 1–3, 1–4, and 1–5 years. 
At a given day in the follow-up and with a chosen 
exposure time windows, a woman was classified as 
working: (i) only day shifts if she only had day shifts 
throughout the time window; (ii) ever non-day/non-night 
shift, if she had ≥1 non-day shift but no night shift in 
the time window; and (iii) ever night shift if she had ≥1 
night shift in the time window.
The cumulated number of night shifts since entry 
was divided into four categories defined by the person-
year quartiles. The mean numbers of night shifts during 
the past 1, 1–2, 1–3, 1–4, and 1–5 years time windows 
were calculated and categorized into four groups: 0.1–
0.9, 1.0–3.9, 4.0–9.9, and ≥10.0 night shifts per month.
Covariates
From the registries, information was retrieved on age, 
age at birth of first child, number of children, a family 
history of either breast cancer before the age of 50 or 
ovarian cancer at any age among female first degree 
relatives (mothers and sisters), use of oral contraception, 
hormone replacement therapy, other hormone medica-
tions in the G03 ATC group, use of medications related 
to alcohol over-consumption and addiction (ATC groups 
N03AA, N05AB and N07BB), highest educational level 
in the family, and attending mammography screening. 
These potential confounders were based on register 
availability, a review of the literature, and decided upon 
a priori (40, 41). Data were virtually complete within the 
time frame of available data for all variables except for 
female first degree relatives (5% missing). Missing val-
ues were evenly distributed across work hour categories.
Statistical analysis
Each woman was followed on a daily basis from start 
of follow-up, which was the first registration of work 
(earliest on 1 January 2007) until the date of first primary 
breast cancer diagnosis, death, disappearance, emigration, 
or end of follow-up at 31 December 2012. In the analyses 
of mean number of night shifts during the past exposure 
time windows, follow-up started subsequent to the end 
of a time window and the earliest one year after the first 
registration of work for the one-year time window.
Data were analyzed as incidence rate, ie, as the num-
ber of incident breast cancer cases per time units at risk. 
We computed rate ratios (RR) of overall breast cancer 
with Poisson regression and breast cancer subtypes by 
stacked Poisson regression by the different night shift 
metrics. The only day shift category was the reference. 
A separate RR estimate was provided for the ever non-
day, non-night category (presented in the supplementary 
material www.sjweh.fi/index.php?page=data-reposi-
tory). The stacked Poisson regression analysis was based 
on a table combining person years at risk and number 
of events for ER-/HER2-, ER+/HER2-, ER-/HER2+, 
ER+/HER2+, and unclassified tumors (no receptor 
status available). This allowed us to test whether the 
association between night shift work and the incidence 
of breast cancer differed between subtypes. Both crude 
and adjusted estimates were reported. 
Age, age at birth of first child, number of children, 
a family history of breast cancer or ovarian cancer, and 
hormone replacement therapy may have distinct effects 
on breast cancer subtypes (42–44). Therefore, we divided 
the potential confounders into two sets of covariates: (A) 
age (<40, 40–44, 45–49, and every second year from age 
50), age at birth of the first child (<20, 20–29, ≥30, no 
children), number of births (0, 1, 2, 3, ≥4), family history 
of breast cancer or ovarian cancer (0, ≥1, no information), 
hormone replacement therapy (no, yes); and (B) calendar 
year (each year 2007–2012), oral contraceptives (no, 
yes), other sex hormones (no, yes), medication related 
to alcoholism, (no, yes), mammography screening atten-
dance (invited but not screened, invited and screened, not 
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invited), and highest family educational level at the first 
registration of work (unspecified, primary and secondary 
school, advanced level education, vocational education, 
undergraduate and bachelor degree, higher education, and 
no information on education). Analyses of overall breast 
cancer included all sets of A and B covariates. In the 
adjusted stacked Poisson regression models, the effects 
of the covariates in set A were allowed to differ between 
breast cancer subtypes while the covariates in set B were 
assumed to have the same effect on the rate independently 
of the subtype. 
All variables were time dependent, ie, varied for 
each date from start until the end of follow-up. Estimates 
were reported with a 95% confidence interval. Two dif-
ferent trend analyses were conducted across the grouped 
cumulated and average number of night shifts; the one 
was restricted to ever night shifts, the other included 
only day shift as a null exposed category. All data man-
agement and analyses were done with Stata 14.1 (Stata 
Corp, College Station, TX, USA).
Results 
The 155 540 women contributed a total of 771 062 per-
son years and 1245 breast cancer cases during follow-up. 
ER status was available for 1177 (95%) cases, HER2 
status for 1123 (90%) cases, and both ER and HER2 
status for 1118 (90%) cases. In total 136 ER-/HER2-, 
797 ER+/HER2-, 77 ER-/HER2+, 108 ER+/HER2+, and 
127 not classifiable (because of missing receptor status) 
breast cancer cases were included. The inception popu-
lation included 55 381 women and contributed a total 
of 199 617 person years and 230 breast cancer cases, 
14  ER-/HER2-, 151  ER+/HER2-, 28 ER-/HER2+, 18 
ER+/HER2+, and 19 not classifiable receptor subtypes. 
Table 1 presents the distribution of age and age-
standardized participant characteristics of person years 
by exposure status (only day shifts and ever night shifts) 
since study entry for the total population. Supplementary 
table A (www.sjweh.fi/index.php?page=data-reposi-
tory) provides this information also for the ever non-
day, non-night shift category and for quartiles of night 
shifts. Women who worked night shifts had a higher 
family educational level and were overall younger than 
women working only day shifts. Except from this, age-
standardized person years were evenly distributed by 
participant characteristics and work hours. Healthcare 
professionals constituted 40%, personal care workers 
23%, technicians 15%, elementary occupations 10%, 
and clerical support workers 5% of the employees. 
In the inception population, more non-night shift 
workers did not have children, and this group was also 
less educated than the night shift workers (data not 
shown). The mean age of the inception population was 
35.5 years compared to 39.4 years in the total population.
Table 2 presents rate ratios for all breast cancer 
and the four breast cancer subtypes defined by the 
cross classification of ER and HER2 status by night 
shifts since entry in the total study population. Over-
all decreased RR for all breast cancer was observed 
Table 1. Age and age-standardized participant characteristics of 
person years (%) among female employees of the Danish public 
sector working only day or ever night shifts 2007–2012. a
Participant characteristics Only day shifts 
(412 920  
person years)
Ever night shifts 
(318 210  
person years)
Age (years)
<40 40 49
40–49 25 25
50–59 23 20
≥60 12 6
Calendar year of follow-up
2007 13 9
2008 16 14
2009 17 17
2010 18 19
2011 18 20
2012 18 21
Age at first child’s birth
<20 years 5 4
20–29 years 53 57
≥30 years 16 16
No children 26 23
Number of children
0 26 23
1 17 17
2 40 39
3 14 18
≥4 3 4
Family history of breast or ovarian cancer
No 90 91
Yes 2 3
No information 8 7
Oral contraception
No 39 38
Yes 61 62
Hormone replacement therapy
No 75 75
Yes 25 25
Other sex hormones
No 88 87
Yes 12 13
Medications for alcoholism
No 98 99
Yes 2 1
Mammography screening 
No 4 4
Yes 16 18
Not invited 80 78
Highest family education
Unspecified 1 1
Primary and secondary school 8 2
Advanced level education 36 25
Vocational education 6 2
Undergraduate and bachelor degree 31 54
Higher education 18 16
Missing 0 0
a A total of 39 932 person years of employees ever working non-day, 
non-night shifts were not included.
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(adjusted RR 0.90, 95% CI 0.80–1.01). The ER+/
HER2- subtype showed a RR of  0.80 (95% CI 0.68–
0.95) and a decreasing trend by increasing number 
of night shifts when day worker were included as a 
null-exposed category in the trend test (P=0.05), but 
not when tested within the night shift workers only. A 
decreased RR was also seen for ER-/HER2- but not of 
statistical significance. 
Non-significantly increased RR were observed for the 
ER-/HER2+ and ER+/HER2+ subtypes (RR 1.49, 95% CI 
0.93–2.39 and RR 1.26, 95% CI 0.84–1.89, respectively). 
For the former subtype, an increasing trend by increasing 
number of night shifts was seen (P<0.05), but not when 
tested within the night shift workers only. 
We observed a decreased association between ever 
working night shift during the past one year time window 
and all breast cancer (RR 0.80, 95% CI 0.69–0.93) and a 
decreasing trend (P=0.01) by the mean number of night 
shifts when day workers were included in the test (table 
3). Such trends were also seen for the other time windows, 
except for the past 1–5 years window, but not when tested 
among the night shift workers only. 
Table 4 presents associations between all breast 
cancer and night shifts since entry and during the past 1 
to 1–4 years time windows in the inception population. 
In the crude analyses, we observed a decreased RR for 
all breast cancer following night shift work the past 1 
year (RR 0.69, 95% CI 0.48–0.98). This association 
was attenuated in the adjusted analyses and none of the 
adjusted RR estimates differed statistically from unity. 
We observed age, age at birth of first child, family 
history of breast cancer or ovarian cancer, mammog-
raphy screening attendance, family educational level 
to be associated with increased breast cancer risk, all 
as expected. Supplementary tables A–D (www.sjweh.
fi/index.php?page=data-repository) correspond with 
tables 1–4 but include comprehensive and more detailed 
data. No increased risk of breast cancer was seen for the 
ever non-day, non-night shifts category in neither the 
total nor the inception population.
Table 2. Rate ratios (RR) and 95% confidence intervals (95% CI) of all breast cancer and combined estrogen receptor (ER) and human 
epidermal growth factor 2 (HER2) breast cancer subtypes by night shifts since start of follow-up. Results from female employees of the 
Danish public sector 2007–2012.
Breast cancer Only day shifts 
(reference) a
Ever night shifts a Test for trend     
P-value I b
Test for trend    
P-value II c
Cases Cases Crude RR 95% CI Adjusted RR d 95% CI
All breast cancer 751 425 0.73 0.65–0.83 0.90 0.80–1.01 0.56 0.10
ER-/HER2- 80 49 0.79 0.56–1.13 0.85 0.59–1.23 0.66 0.46
ER+/HER2- 503 250 0.64 0.55–0.75 0.80 0.68–0.95 0.33 0.05
ER-/HER2+ 37 37 1.30 0.82–2.05 1.49 0.93–2.39 0.67 <0.05
ER+/HER2+ 55 48 1.13 0.77–1.67 1.26 0.84–1.89 0.18 0.51
a The distribution of person years by exposure is shown in supplementary table B (www.sjweh.fi/index.php?page=data-repository).
b Test for trend by number of night shifts among night shift workers, adjusted P-value. See supplementary table B for definition of night shift categories. 
c Test for trend by number of night shifts among night and day shift workers. 
d Poisson regression model adjusted for calendar year, age, age at birth of first child, number of births, family history of breast cancer or ovarian cancer, 
oral contraception, hormone replacement therapy, other sex hormones, medication related to alcoholism, mammography screening attendance, and 
highest family educational level. For details, refer to the text.
Table 3. Rate ratios (RR) and 95% confidence intervals (95% CI) of all breast cancer by night shifts during the past 1 to 1–5 years time 
windows. Results from female employees of the Danish public sector 2008–2012. 
Time  
window
Only day shifts  
(reference)
Ever night shifts Test for  
trend  
P-value I a
Test for  
trend  
P-value II bPerson years Cases Person years Cases Crude RR 95% CI Adjusted RR c 95% CI
Past 1 year 399 092 748 181 375 220 0.64 0.55–0.74 0.80 0.89–0.93 0.39 0.01
Past 1–2 years 465 255 822 160 800 218 0.84 0.54–1.30 0.89 0.72–1.10 0.64 0.04
Past 1–3 years 192 055 397 123 451 170 0.67 0.56–0.80 0.83 0.69–1.00 0.87 0.04
Past 1–4 years 110 486 240 80 153 110–114 d 0.64 0.51–0.80 0.80 0.64–1.01 0.87 0.05
Past 1–5 years 43 611 113 35 783 69 0.75 0.56–1.01 0.97 0.71–1.32 0.62 0.70
a Test for trend by mean number of night shifts during the specified time interval among night shift workers, adjusted p value. See supplementary table C 
(www.sjweh.fi/index.php?page=data-repository) for definition of night shift categories. 
b Test for trend by mean number of night shifts during the specified time interval among night shift and day shift workers, adjusted P-value. 
c Poisson regression model adjusted for calendar year, age, age at birth of first child, number of births, family history of breast cancer or ovarian cancer, 
oral contraception, hormone replacement therapy, other sex hormones, medication related to alcoholism, mammography screening attendance, and 
highest family educational level. For details, refer to the text. 
d According to the data confidentiality policy of Statistics Denmark no less than 4 cases per cell must be reported. Providing the exact total here would al-
low the calculation of cases in cells with less than 4 cases in supplementary table C (www.sjweh.fi/index.php?page=data-repository). 
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Discussion
In this large population of women with a high preva-
lence of night shift work, we observed no elevated risk 
of all breast cancer following recent night shift work. 
Modestly increased risks were suggested for HER2+ 
but not for HER2- breast cancer subtypes irrespective 
of ER status, but these findings were based on relatively 
few observations. 
We could not corroborate a short-term effect of night 
shift work on the risk of breast cancer as suggested by 
experimental data (10, 16). This finding is consistent 
with that of Fritschi et al (20) and Pesch et al (18) who 
observed no elevated risk among women working night 
shifts within the recent ten years [odds ratios (OR) 
1.02, 95% CI 0.73–1.43 and 1.04, 95% CI 0.31–3.53, 
respectively]. However, our findings are not consistent 
with the findings of Davis et al who observed a slightly 
elevated risk during the recent ten years of night shift 
work (OR 1.6, 95% CI 1.0–2.5) (19). As opposed to our 
study, these studies relied on self-reported information 
on night shift work and had limited statistical power.
The association between night shift work and HER2+ 
breast cancer has been examined in three previous stud-
ies. Wang et al (28), Papantoniou et al (31), and Cordina-
Duverger et al (29) all suggested increased associations 
between HER2+ tumors and night shift work (OR 1.35, 
95% CI 0.94–1.94; OR 1.31, 95% CI 0.93–1.85; and 
OR 1.91, 95% CI 1.09–3.33, respectively). Cordina-
Duverger et al cross classified HER2 and hormone 
receptor status as we did and observed an OR of 2.52 
(95% CI 1.36–4.68) for HER2+ in combination with 
ER+ or PR+ but no association for HER2+ in combina-
tion with ER- or PR- receptor status (OR 0.75, 95% CI 
0.16–3.38) and were thus only partly in agreement with 
our findings (29). ER+/HER2- tumors constituted 88% 
of the ER+ tumors in this material and the decreased risk 
we observed for this subtype is not supportive of earlier 
studies showing associations between night shift work 
and ER+ tumors (without information on HER2 receptor 
status) (25–28). Experimental studies implicate melato-
nin suppression in HER2+ carcinogenesis (45, 46).
 The increasing and decreasing trends observed by 
cumulative and average number of night shifts were only 
seen when day workers were included as a null-exposed 
category in the trend tests and not when tested among 
night shift workers only. This points more towards a 
night shift worker effect than an effect of night shift 
work per se.
Strengths and limitations
A major strength of this study was the objective and 
detailed day-to-day information on working hours from 
a payroll register that is presumed to be complete for 
the years 2007–2012. Since the salary varies by work-
ing hours during the day and week, these recordings 
are expected to be precise and valid given that employ-
ers and employees have a common interest in correct 
recordings. We did not have access to information that 
made validation of the payroll data possible but a recent 
evaluation of comparable Finnish payroll data showed 
that the retrieved register data matched originally pub-
lished shift plans (47). 
The detailed work hour data allowed us to define a ref-
erence category of only day shifts that included no early 
morning or late evening shifts that could have affected 
circadian regulation and thus diluted a possible effect of 
night shifts. We observed no association between ever 
non-day, non-night shifts, and breast cancer.  
Cases of breast cancer were identified in national 
registers encompassing all breast cancers diagnosed 
in Denmark since 1943 and information on HER2 and 
ER receptor status was recorded for a high proportion 
of cases (33, 34). Thus, because we relied only on 
registers with high coverage and completeness and no 
self-reports, information bias is unlikely. 
Based on the extensive register data, we were able 
to account for major reproductive factors, hormonal 
treatment, and family history of breast cancer, which 
are all well-established risk factors for breast cancer. 
Table 4. Rate ratios (RR) and 95% confidence intervals (95% CI) of all breast cancer by night shift work since entry and during the past 1 
to 1–4 years time windows. Results from female employees from the inception population with first recorded employment in the Danish 
public sector 2008–2012.
Time window Only day shifts (reference) Ever night shifts
Person years Cases Person years Cases Crude RR 95% CI Adjusted RR a 95% CI
Since entry 116 823 144 71 113 69 0.77 0.58–1.03 0.88 0.66–1.17
Past 1 year 98 747 128 40 208 37 0.69 0.48–0.98 0.82 0.56–1.18
Past 1–2 years 60 066 78 31 217 36 0.89 0.60–1.33 1.14 0.76–1.71
Past 1–3 years 30 965 43 18 828 29 1.13 0.71–1.81 1.33 0.82–2.17
Past 1–4 years 10 547 15 7390 10 0.96 0.43–2.14 1.01 0.44–2.32
a Poisson regression model adjusted for calendar year, age, age at birth of first child, number of births, family history of breast cancer or ovarian cancer, 
oral contraception, hormone replacement therapy, other sex hormones, medication related to alcoholism, mammography screening attendance, and 
highest family  educational level. For details, refer to the text. 
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During recent years, the possible risk of breast cancer 
following night shift work has attracted public interest 
in Denmark (48). For that reason, night shift workers 
may have been more willing to participate in breast 
cancer screening programs and thus more likely to be 
diagnosed with breast cancer than day workers. We had 
access to national mammography screening data and 
could therefore also adjust for this possible confounder. 
We used prescription of medications related to alco-
holism as a surrogate measure for alcohol consumption 
(involving about 1–2% of the population). This will to 
some extent account for severe alcohol consumption.
Income was not expected to vary substantially in 
this rather homogenous study population, and therefore 
we adjusted for the highest education in the family as a 
surrogate measure for socioeconomic status. 
There were also limitations. Several epidemiological 
studies have observed an increased risk of breast cancer 
following long-term night shift work that we were not 
able to assess due to lack of work schedule data prior 
to 2007 (18, 25, 27, 49–52). An unknown part of the 
cohort subjects employed during 2007–2012 were hired 
prior to 2007 where we have no information on working 
time. They may represent a subset less susceptible to 
the effects of night shift work. Such left truncation bias 
is expected to provide underestimates of risk and could 
explain our decreased risks in several of the analyses 
(53). We therefore defined an inception population 
with no recorded employment during a one-year wash-
out period in 2007 that included one third of the total 
population. Results from this population should not be 
affected to the same extent by left truncation bias by 
previous night shift work. However, the results were in 
line with those from the total study population, but based 
on small numbers. It should, however, be stressed that 
the mean age of the inception population was 35.5 years 
which implies that many have had employment prior to 
2007, with and without night shift work.
Long-term night shift work beginning prior to 2007 
could have confounded our findings for recent night 
shift work, if causally related with breast cancer. But 
this should only be the case if recent night shift work 
is inversely associated with long-term night shift work. 
In our opinion, this is perhaps an unlikely explanation. 
We were not able to account for chronotype or 
diurnal preference, alcohol habits in the lower and 
average end, age at menarche and menopause, obesity, 
and physical activity, all well-documented risk factors 
for breast cancer and potential confounders. Previous 
studies on night shift work and breast cancer have only 
reported  minor confounding effects from these expo-
sures, if any (54).
Although the study population is large, the amount 
of exposed person time was small in several of the sub-
analyses and the statistical power thus limited. 
Concluding remarks
We observed no increased risk of all breast cancer fol-
lowing recent night shift work. A modestly increased 
risk was suggested for breast cancer subtypes char-
acterized by positive HER2 status. These findings do 
not support an overall short-term effect of night shift 
work. Future studies should explore further the impact 
of HER2 status. 
From a policy perspective, these results are reassur-
ing for the many women working night shifts, but only 
in the short run. It is still unclear if night shift work 
effects long-term breast cancer risk or the risk of breast 
cancer subtypes.
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